Navigation Links
Gemin X Announces Publication of Preclinical Data of GX15-070 in,Multiple Myeloma in Blood

MONTREAL & MALVERN, Pa.--(BUSINESS WIRE)--Mar 7, 2007 - Gemin X announced today that a report published in the online version of the journal Blood demonstrated that its lead compound, GX15-070 (obatoclax), induced potent cytotoxic responses against patient-derived multiple myeloma tumor cells as a single-agent, and enhanced anti-myeloma effects when used as a combination therapy. GX15-070 is a small molecule specifically designed to inhibit all relevant members of the Bcl-2 protein family, a validated cancer target, restoring the natural cell death process of apoptosis.

"The ability of GX15-070 to inhibit tumor progression and also enhance the effects of other treatment modalities that often suffer from resistance is encouraging," stated Gordon Shore, Ph.D., Chief Scientific Officer of Gemin X. "This study describes the novel activity of this compound and supports its therapeutic use in diverse cancer types, including multiple myeloma."

In the preclinical studies, GX15-070 potently inhibited the viability of 15 of 16 human myeloma cell lines (HMCLs), including those resistant to treatment with melphalan (a chemotherapeutic) and dexamethasone (a corticosteroid). Combination studies with GX15-070 demonstrated that it enhanced the anti-myeloma activity stimulated by melphalan, dexamethasone, and bortezomib, a proteosome inhibitor. Additionally, single-agent studies of the candidate showed that it induced potent cytotoxic responses against patient-derived tumor cells without inducing cytotoxicity to human blood lymphocytes.

Gemin X is currently conducting several clinical trials of GX15-070 in multiple cancer types as a combination therapy and as a single agent. Gemin X recently initiated a Phase 1 trial with GX15-070 in combination with bortezomib in patients with mantle cell lymphoma (MCL) and a Phase 1/2 clinical trial in combination with docetaxel in patients with non-small cell lung cancer. G
'"/>




Page: 1 2

Related medicine technology :

1. Gemin X Biotechnologies Announces Publication in Blood of Positive Preclinical Data of Lead Compound in Mantle Cell Lymphoma
2. Gemin X Presents Positive Preclinical Data of GX15-070 in Infant ALL at AACR Meeting
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
(Date:6/19/2013)... 2013 /PRNewswire-iReach/ -- Today leading web researchers Change Sciences ... Pharmaceutical web sites for usability, engagement, and conversion. The ... platform, which compares how people experience sites with competitors ... The top three performers are easier to use, ... bottom performers have usability problems, lack aspects of design ...
(Date:6/19/2013)... , June 19, 2013 /PRNewswire-iReach/ -- ... a new specialty pharmaceutical company dedicated to ... innovative injectable and sustained release drug therapies ... medical needs, today announced the acquisition of ... Technology®) platform and associated product pipeline. Acquisition ...
(Date:6/19/2013)... June 19, 2013  Omnicell, Inc. (NASDAQ: ... and supply management solutions and analytics software for ... the number one overall pharmacy equipment vendor in ... KLAS, a leading independent healthcare research firm, compared ... in its annual rankings. Omnicell also received the ...
Breaking Medicine Technology:Sunovion tops new Change Sciences User Experience Rankings for Pharmaceutical Industry while McNeil-PPC ranks worst overall 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 4Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 2Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 3Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 4
(Date:6/19/2013)... 2013 Brand new Hypertrophy Max bonus just released ... sale on the Hypertrophy Max program. Vince and Ben are ... those that are interested must act quickly. , What is the ... bonus is a free 12 month all access pass to the ... Ryan Davids "Live Large TV is a Monday night show where ...
(Date:6/19/2013)... Neb. (PRWEB) June 20, 2013 Author Byron ... give children a basic explanation of how the body’s defense ... Brownie Bill and the Health Pirates ” (published by Trafford ... and the Health Pirates” tells the story of Bobbie, a ... fever one morning. His mother takes him to visit Doctor ...
(Date:6/19/2013)... Colorado (PRWEB) June 19, 2013 Daily Gossip ... vertical jump training method will be published on their ... preview of the article to inform readers about the information ... declaration made by reporters working at Daily Gossip, the article ... Guide . , Hiller has understood during the vast ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 PrettySkin4Less announces ... organic skin serums by top skin care manufacturer ... high concentrations of vitamins, minerals and active organic ingredients ... that so many other beauty products offer. For this ... lining up. , "I like products that do ...
(Date:6/19/2013)... UT (PRWEB) June 19, 2013 ... , In July 2013, Orriant is launching a ... rates, and maintain compliance with regulations. New ... to receive wellness incentives if their employer offers ... they have been compliant with these standards for ...
Breaking Medicine News(10 mins):Health News:New Hypertrophy Max Bonus Just Released and Only Available for 24 Hours 2Health News:New Book Shows Children How the Body Fights Germs 2Health News:The Jump Manual Review: Reveals Hiller’s Method of Vertical Jump Training 2Health News:PrettySkin4Less Launches New Innovative Skin Serums with Active Organic Ingredients to World Wide Consumer Base 2Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 2Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 3
... common type of disorder in which the patient develops tingling and ... approved the drug to be sold to treat the disorder. It ... about 10% of the people are affected by this disorder. ... of now it is used to treat mild to moderate or ...
... here lawyers in California have sued PepsiCo alleging one of ... drink in question is Pepsi Twist drink, and it is ... firms has been drawn into a legal battle. ,Lawyers ... Twist has been falsely promoted as a safe consumer product, ...
... the anti-quota camp, the Supreme Court Friday reversed an ... seats on an all-India basis// for scheduled castes and ... 2006-07 academic year. ,A bench of judges K.G. ... of Additional Solicitor General Gopal Subramaniam that enforcing the ...
... of Orissa, declared that his health is normal. // The ... after he ran an astounding 65km earlier this week. ... Bhubaneswar for a medical check up on the orders of ... Biranchi Das was exploiting the boy for his personal gains. ...
... India (MCI) has condemned the poor infrastructure, lack lustre teaching ... // ,The (MCI) delegation, headed by Dr Lalita ... college and its failure to set up proper infrastructure over ... the college building was another factor of contention and a ...
... Lomb Inc. is in serious trouble after an eye infection ... its lens care products.// There are complaints arising from Asia, ... lens care products might be linked to a spate of ... a handful of cases of the infection had also been ...
Cached Medicine News:Health News:Supreme Court Quashed Reservation Quotas For PG Medical Courses 2Health News:Marathon Kid Budhia’s Health Not Compromise 2
Medpor 2/3 Orbit implants are designed to replace non load bearing bony structures in the orbital area....
... Orbital Rim implant can provide up to ... to be trimmed to meet the needs ... allows it to rest on the most ... flange allows easier positioning of the implant ...
Flattened points in vertical plane, straight shafts, cross action, round handle....
1.5 mm inner cutting edge....
Medicine Products: